Geode Capital Management LLC Has $155.18 Million Stock Position in Encompass Health Co. (NYSE:EHC)

Geode Capital Management LLC boosted its holdings in Encompass Health Co. (NYSE:EHC) by 0.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,679,774 shares of the company’s stock after purchasing an additional 6,164 shares during the period. Geode Capital Management LLC’s holdings in Encompass Health were worth $155,176,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB increased its stake in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares during the period. CBIZ Investment Advisory Services LLC increased its position in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after purchasing an additional 127 shares during the period. Tompkins Financial Corp acquired a new position in shares of Encompass Health in the fourth quarter valued at $46,000. V Square Quantitative Management LLC lifted its position in Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after purchasing an additional 177 shares during the period. Finally, Signaturefd LLC boosted its stake in Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company’s stock worth $65,000 after buying an additional 125 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on EHC. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research note on Tuesday, February 11th. Barclays raised their target price on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. StockNews.com cut Encompass Health from a “buy” rating to a “hold” rating in a research report on Thursday, April 3rd. Finally, KeyCorp lifted their price objective on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Monday, February 10th. One research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $107.67.

Insider Buying and Selling at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Stock Down 1.2 %

Shares of NYSE:EHC opened at $96.75 on Tuesday. Encompass Health Co. has a 12 month low of $78.53 and a 12 month high of $104.55. The firm has a market cap of $9.74 billion, a P/E ratio of 21.69, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The company’s 50-day moving average price is $99.26 and its two-hundred day moving average price is $97.78.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, research analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.70%. Encompass Health’s dividend payout ratio is currently 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.